Group One Trading’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.56M | Sell |
470,200
-184,800
| -28% | -$1.04M | ﹤0.01% | 1852 |
|
|
2025
Q4 | $4.58M | Sell |
655,000
-143,300
| -18% | -$1.12M | 0.01% | 1583 |
|
|
2025
Q3 | $6.17M | Buy |
798,300
+160,700
| +25% | +$1.25M | 0.01% | 1303 |
|
|
2025
Q2 | $5.55M | Sell |
637,600
-475,000
| -43% | -$3.44M | 0.01% | 1246 |
|
|
2025
Q1 | $8.86M | Buy |
1,112,600
+958,800
| +623% | +$9.7M | 0.03% | 694 |
|
|
2024
Q4 | $1.4M | Buy |
153,800
+40,900
| +36% | +$395K | ﹤0.01% | 2239 |
|
|
2024
Q3 | $1.04M | Buy |
112,900
+18,800
| +20% | +$156K | ﹤0.01% | 2259 |
|
|
2024
Q2 | $920K | Sell |
94,100
-32,900
| -26% | -$401K | ﹤0.01% | 2056 |
|
|
2024
Q1 | $1.92M | Sell |
127,000
-346,500
| -73% | -$6.29M | 0.01% | 1506 |
|
|
2023
Q4 | $10.2M | Buy |
473,500
+110,500
| +30% | +$2.04M | 0.03% | 698 |
|
|
2023
Q3 | $6.75M | Buy |
363,000
+1,000
| +0.3% | +$23.3K | 0.02% | 745 |
|
|
2023
Q2 | $9.17M | Sell |
362,000
-70,300
| -16% | -$1.77M | 0.03% | 556 |
|
|
2023
Q1 | $11.2M | Sell |
432,300
-704,800
| -62% | -$18.9M | 0.04% | 416 |
|
|
2022
Q4 | $26.9M | Sell |
1,137,100
-363,300
| -24% | -$9.8M | 0.06% | 311 |
|
|
2022
Q3 | $38M | Sell |
1,500,400
-12,400
| -0.8% | -$435K | 0.07% | 183 |
|
|
2022
Q2 | $50.2M | Sell |
1,512,800
-330,100
| -18% | -$14M | 0.08% | 198 |
|
|
2022
Q1 | $133M | Sell |
1,842,900
-867,700
| -32% | -$62.5M | 0.13% | 84 |
|
|
2021
Q4 | $249M | Buy |
2,710,600
+143,900
| +6% | +$17.2M | 0.2% | 51 |
|
|
2021
Q3 | $325M | Buy |
2,566,700
+1,012,900
| +65% | +$147M | 0.35% | 34 |
|
|
2021
Q2 | $258M | Buy |
1,553,800
+1,264,700
| +437% | +$205M | 0.31% | 33 |
|
|
2021
Q1 | $52.5M | Sell |
289,100
-192,200
| -40% | -$44.6M | 0.08% | 197 |
|
|
2020
Q4 | $96.2M | Buy |
481,300
+190,300
| +65% | +$38.7M | 0.17% | 69 |
|
|
2020
Q3 | $63.8M | Buy |
291,000
+24,900
| +9% | +$5.27M | 0.2% | 70 |
|
|
2020
Q2 | $50.8M | Sell |
266,100
-89,600
| -25% | -$15.7M | 0.23% | 63 |
|
|
2020
Q1 | $55.1M | Buy |
355,700
+110,400
| +45% | +$12.8M | 0.45% | 27 |
|
|
2019
Q4 | $20.5M | Buy |
245,300
+151,200
| +161% | +$11.5M | 0.14% | 140 |
|
|
2019
Q3 | $6.37M | Buy |
94,100
+46,100
| +96% | +$3.03M | 0.05% | 454 |
|
|
2019
Q2 | $3.19M | Buy |
48,000
+2,300
| +5% | +$134K | 0.03% | 780 |
|
|
2019
Q1 | $2.54M | Sell |
45,700
-37,300
| -45% | -$2.28M | 0.03% | 772 |
|
|
2018
Q4 | $4.11M | Buy |
83,000
+38,400
| +86% | +$2.35M | 0.04% | 609 |
|
|
2018
Q3 | $3.85M | Buy |
44,600
+11,500
| +35% | +$820K | 0.03% | 728 |
|
|
2018
Q2 | $1.92M | Buy |
33,100
+13,400
| +68% | +$654K | 0.02% | 1171 |
|
|
2018
Q1 | $794K | Sell |
19,700
-55,300
| -74% | -$2.09M | 0.01% | 1685 |
|
|
2017
Q4 | $2.61M | Buy |
75,000
+32,800
| +78% | +$1.09M | 0.02% | 1033 |
|
|
2017
Q3 | $1.4M | Buy |
42,200
+7,100
| +20% | +$233K | 0.01% | 1325 |
|
|
2017
Q2 | $1.22M | Sell |
35,100
-7,600
| -18% | -$221K | 0.01% | 1302 |
|
|
2017
Q1 | $1.07M | Buy |
+42,700
| New | +$888K | 0.01% | 1300 |
|
|
2016
Q4 | – | Sell |
-5,900
| Closed | -$108K | – | 4839 |
|
|
2016
Q3 | $108K | Sell |
5,900
-1,700
| -22% | -$29.8K | ﹤0.01% | 2880 |
|
|
2016
Q2 | $122K | Buy |
+7,600
| New | +$88.7K | ﹤0.01% | 2729 |
|
Other funds holding TDOC
VPM
VCM
VC
Group One Trading's TDOC Position: Q1 2026 in Review
Group One Trading increased its Teladoc Health (TDOC) stake by 40% in Q1 2026, buying an estimated $340K and bringing the position to 212,759 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2574.
Group One Trading first reported a position in TDOC in Q3 2017 and has held it in 26 quarters since. The position peaked at $54M in Q1 2021. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.
- Group One Trading held 212,759 shares of Teladoc Health worth $1.16M as of Q1 2026.
- Group One Trading bought 60,560 Teladoc Health shares in Q1 2026, an estimated $340K.
- Teladoc Health made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2574 holding.
- Group One Trading first reported a position in Teladoc Health in Q3 2017 and has held it in 26 quarters since.
- Group One Trading's Teladoc Health position peaked at $54M in Q1 2021.
- 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.